U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2016
495
Substance Class Protein
Created
by admin
on Sat Dec 16 17:37:21 GMT 2023
Edited
by admin
on Sat Dec 16 17:37:21 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
52CMI0WC3Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ATEZOLIZUMAB
DASH   INN   USAN   WHO-DD  
INN   USAN  
Official Name English
ATEZOLIZUMAB [USAN]
Common Name English
TECENTRIQ
Common Name English
RG-7446
Code English
ATEZOLIZUMAB [JAN]
Common Name English
MPDL3280A
Code English
ATEZOLIZUMAB [MI]
Common Name English
atezolizumab [INN]
Common Name English
AN ANTIBODY TO PROGRAMMED DEATH LIGAND 1 FOR CANCER THERAPY
Common Name English
ATEZOLIZUMAB [PURPLE BOOK CDER]
Common Name English
0INE2SFD9E
Common Name English
RG7446
Code English
Atezolizumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MPDL3280A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MPDL3280A .KAPPA.-CHAIN, DIMER
Common Name English
MPDL-3280A
Code English
Classification Tree Code System Code
WHO-ATC L01XC32
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 574817
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 619317
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 792320
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 769320
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 541216
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
FDA ORPHAN DRUG 550616
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
NDF-RT N0000191260
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
NCI_THESAURUS C128057
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL3707227
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
LACTMED
Atezolizumab
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
DRUG BANK
DB11595
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
WIKIPEDIA
Atezolizumab
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
SMS_ID
100000163921
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
NCI_THESAURUS
C106250
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
EVMPD
SUB178312
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
NDF-RT
N0000011175
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY Antibodies [Chemical/Ingredient]
NDF-RT
N0000183512
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY Antibodies, Monoclonal, Humanized [Chemical/Ingredient]
DAILYMED
52CMI0WC3Y
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
INN
9814
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
FDA UNII
52CMI0WC3Y
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
CAS
1380723-44-3
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
USAN
CD-146
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
RXCUI
1792776
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
DRUG CENTRAL
5151
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
CAS
1422185-06-5
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
NO STRUCTURE GIVEN
MERCK INDEX
m11954
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY
NDF-RT
N0000191259
Created by admin on Sat Dec 16 17:37:21 GMT 2023 , Edited by admin on Sat Dec 16 17:37:21 GMT 2023
PRIMARY Programmed Death Receptor-1-directed Antibody Interactions [MoA]
From To
1_22 1_96
1_145 1_201
1_262 1_322
1_368 1_426
2_22 2_96
2_145 2_201
2_262 2_322
2_368 2_426
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_221 3_214
2_221 4_214
1_227 2_227
1_230 2_230
Related Record Type Details
PROGRAMMED CELL DEATH 1 LIGAND 1
TARGET -> INHIBITOR
BINDING
Related Record Type Details
ATEZOLIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Molecular Formula CHEMICAL
Biological Half-life PHARMACOKINETIC
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966